Lab Information
Waqqas Afif (MD/MSc)
InvestigatorClinical Research Unit
Department of Medicine (McGill)
Research Profile
Keywords
Inflammatory bowel disease • Crohn's disease • ulcerative colitis • biologic medications • therapeutic drug monitoringResearch Interests
My research focuses on the safety and efficiency of biologic medications in the treatment of IBD. I am interested in the use of therapeutic drug monitoring to optimize the treatment of IBD patients on biologic medications.Team Members
| Name | Position |
|---|
Latest Publications
- Gorodensky, J. H., Bernatsky, S., Afif, W., St-Pierre, Y., Filion, K. B. & Vinet, É. (2023). Serious Infections in Offspring Exposed in Utero to Vedolizumab. Inflammatory bowel diseases.
- Wetwittayakhlang, P., Verdon, C., Starr, M., Hahn, G. D., Golovics, P. A., Bessissow, T., Afif, W., Wild, G., Bitton, A. & Lakatos, P. L. (2023). Mucosal Healing and Clinical Efficacy of Adalimumab in Small Intestinal Crohn's Disease (SIMCHA Study): Final Results From a Prospective, Open-Label, Single-Arm Study. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.
- Kablawi, D., Aljohani, F., Palumbo, C. S., Restellini, S., Bitton, A., Wild, G., Afif, W., Lakatos, P. L., Bessissow, T. & Sebastiani, G. (2023). Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases. Crohn's & colitis 360, vol. 5, p. otad004.
- Wetwittayakhlang, P., Golovics, P. A., Khoury, A. A., Ganni, E., Hahn, G. D., Cohen, A., Wyse, J., Bradette, M., Bessissow, T., Afif, W., Wild, G., Bitton, A. & Lakatos, P. L. (2022). Adherence to Objective Therapeutic Monitoring and Outcomes in Patients with Inflammatory Bowel Disease with Adalimumab Treatment. A Real-world Prospective Study. Journal of gastrointestinal and liver diseases : JGLD, vol. 31, p. 403-410.
- Heron, V., Li Fraine, S., Panaccione, N., Restellini, S., Germain, P., Candido, K., Bernstein, C. N., Bessissow, T., Bitton, A., Chauhan, U. K., Lakatos, P. L., Marshall, J. K., Michetti, P., Seow, C. H., Rosenfeld, G., Panaccione, R. & Afif, W. (2022). Efficacy of Intravenous Ustekinumab Reinduction in Patients With Crohn's Disease With a Loss of Response. Journal of the Canadian Association of Gastroenterology, vol. 5, p. 208-213.
- Hahn, G. D., LeBlanc, J.-F., Golovics, P. A., Wetwittayakhlang, P., Qatomah, A., Wang, A., Boodaghians, L., Liu Chen Kiow, J., Al Ali, M., Wild, G., Afif, W., Bitton, A., Lakatos, P. L. & Bessissow, T. (2022). Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study. World journal of gastroenterology, vol. 28, p. 4823-4833.
- Hahn, G. D., Golovics, P. A., Wetwittayakhlang, P., Santa Maria, D. M., Britto, U., Wild, G. E., Afif, W., Bitton, A., Bessissow, T. & Lakatos, P. L. (2022). Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Journal of clinical medicine, vol. 11.
- Rivière, P., Kanters, C., Pellet, G., Ni, A., Hupé, M., Aboulhamid, N., Poullenot, F., Bitton, A., Zerbib, F., Lakatos, P. L., Afif, W., Laharie, D. & Bessissow, T. (2023). Comparative Effectiveness of Ustekinumab and Anti-TNF Agent as First-Line Biological Therapy in Luminal Crohn's Disease: A Retrospective Study From 2 Referral Centers. Inflammatory bowel diseases, vol. 29, p. 923-931.
- Bessissow, T., Kron, C. M., Marcus, V., Lemieux, C., Laneuville, J., Afif, W., Wild, G., Lakatos, P. L., Brassard, P. & Bitton, A. (2022). Impact of Endoscopic and Histologic Activity on Disease Relapse in Ulcerative Colitis. The American journal of gastroenterology, vol. 117, p. 1632-1638.
- Farid, D., Li, P., Da Costa, D., Afif, W., Szabo, J., Dasgupta, K. & Rahme, E. (2022). Depression, diabetes and immigration status: a retrospective cohort study using the Canadian Longitudinal Study on Aging. CMAJ open, vol. 10, p. E508-E518.
See also
